New drugs for the treatment of lung cancer. The Tokyo Cooperative Oncology Group.
Niitani
H
H
Fukuoka
M
M
Furuse
K
K
Kudoh
S
S
Kurita
Y
Y
Ohnoshi
T
T
Saijoh
N
N
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001952:Bridged-Ring Compounds / Q000627:therapeutic use; D002166:Camptothecin / Q000627:therapeutic use; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D003841:Deoxycytidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D009944:Organoplatinum Compounds / Q000627:therapeutic use; D043823:Taxoids; D014748:Vinca Alkaloids / Q000627:therapeutic use; D000093542:Gemcitabine
D000970:Antineoplastic Agents; D001952:Bridged-Ring Compounds; D009944:Organoplatinum Compounds; D043823:Taxoids; D014748:Vinca Alkaloids; D003841:Deoxycytidine; C080625:taxane; C053989:nedaplatin; D002166:Camptothecin; D000093542:Gemcitabine